5 health tech financial trends to know from 2022

U.S. health tech venture capital investment was healthy in 2022 despite an economic downturn, according to a Jan. 6 report from SVB, the parent of Silicon Valley Bank.  

Advertisement

SVB’s “Healthcare Investments and Exits” report provides information on venture capital fundraising, investments, and merger and acquisition and initial public offering trends. Here’s some trends they found about health tech investments, mergers and acquisitions, and initial public offerings:

  1. Health tech funding shifted toward early-stage investment, where valuations were less impacted by public market comps.
  2. Investment in health tech exceeded the record seed/series A activity from 2021.
  3. IPOs halted as public health tech stock performance fell throughout 2022. However, merger and acquisition volume has remained strong, almost on pace with 2021’s record.
  4. Public (and private) healthcare companies led health tech mergers and acquisitions in 2022.
  5. Private merger and acquisition deals were smaller in value for health tech compared to the previous two years.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.